New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

Sana Biotechnology, Inc

Contributing Author

Recent Articles by Sana Biotechnology, Inc

Jan-07	Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference SANA GlobeNewswire
Dec-08	Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform SANA GlobeNewswire
Nov-24	Sana Biotechnology to Present at December 2025 Investor Conferences SANA GlobeNewswire
Nov-06	Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates SANA GlobeNewswire
Nov-04	Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit SANA GlobeNewswire
Aug-26	Sana Biotechnology to Present at September 2025 Investor Conferences SANA GlobeNewswire
Aug-20	Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares SANA GlobeNewswire
Aug-11	Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates SANA GlobeNewswire
Aug-06	Sana Biotechnology Announces Pricing of Public Offering SANA GlobeNewswire
Aug-06	Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants SANA GlobeNewswire
Aug-04	Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes SANA GlobeNewswire
Jun-23	Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression SANA GlobeNewswire
Jun-09	Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions SANA GlobeNewswire
May-28	Sana Biotechnology to Present at June 2025 Investor Conferences SANA GlobeNewswire
May-12	Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference SANA GlobeNewswire
May-08	Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates SANA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.